Ontology highlight
ABSTRACT: Objective
Widespread metabolic changes are seen in neurodegenerative disease and could be used as biomarkers for diagnosis and disease monitoring. They may also reveal disease mechanisms that could be a target for therapy. In this study we looked for blood-based biomarkers in syndromes associated with frontotemporal lobar degeneration.Methods
Plasma metabolomic profiles were measured from 134 patients with a syndrome associated with frontotemporal lobar degeneration (behavioural variant frontotemporal dementia n = 30, non fluent variant primary progressive aphasia n = 26, progressive supranuclear palsy n = 45, corticobasal syndrome n = 33) and 32 healthy controls.Results
Forty-nine of 842 metabolites were significantly altered in frontotemporal lobar degeneration sy
SUBMITTER: Murley AG
PROVIDER: S-EPMC7359154 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature